Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Draft Ordinance Published in Preparation for Full Enforcement of Amended PAL
September 29, 2008
- NanoCarrier Ties Up with Taiwan Company for Nanoplatin
September 29, 2008
- Pfizer to Start Clinical Trial for Fibromyalgia
September 29, 2008
- Bristol-Myers Applies for Abatacept
September 29, 2008
- R&D NEWS IN BRIEF
September 29, 2008
- NEW PRODUCTS／Kyowa Medex Launches New Reagent to Determine HDL-C
September 29, 2008
- NEW PRODUCT／Julina Launched as Japan's First Oral Estradiol Product
September 29, 2008
- Will Distribution Practices Be Improved? Part 3
September 29, 2008
- TOPICS／Prof. Yamanaka's iPS Cell Preparation Method Patented in Japan
September 29, 2008
- Drugs Will Continue to Be a Core Business of New Meiji Company
September 29, 2008
- Number of Centenarians Up to 36,276
September 29, 2008
- 75% of People Dissatisfied with Current Social Security System
September 29, 2008
- REGULATORY NEWS IN BRIEF
September 29, 2008
- Gardasil Reduces Patients' Burden: Merck
September 29, 2008
- Korosho to Actively Hire Ex-Employees of Pharma Companies
September 29, 2008
- Blood Donations Falling Sharply among Young People
September 29, 2008
- PhRMA to Present Comments on Draft GL for Biosimilars Announced by Korosho
September 29, 2008
- Number of Lifestyle Disease-Free Persons Increases for First Time
September 29, 2008
- Draft GL Announced for Approval of Biosimilars
September 29, 2008
- Measles Vaccination Rates Remain Under 40% in Teenagers: Korosho Survey
September 29, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…